TLX ▲ +9.2% - Telix Pharmaceuticals Limited $TLX - FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara Telix Pharmaceuticals rose 9.2% after the FDA approved Pixclara, its brain cancer imaging drug, a regulatory milestone that clears the way for commercial deployment of the product in the U.S. market. 14-SEP-2026 06:30 AM ET